Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study

Peer Review reports

Original Submission
11 Dec 2021	Submitted	Original manuscript
4 Feb 2022	Reviewed	Reviewer Report - Umang Agrawal
19 Mar 2022	Reviewed	Reviewer Report
30 May 2022	Reviewed	Reviewer Report
15 Jun 2022	Author responded	Author comments - Yao-kai Chen
Resubmission - Version 2
15 Jun 2022	Submitted	Manuscript version 2
17 Jun 2022	Author responded	Author comments - Yao-kai Chen
Resubmission - Version 3
17 Jun 2022	Submitted	Manuscript version 3
22 Jun 2022	Reviewed	Reviewer Report
25 Jul 2022	Reviewed	Reviewer Report
8 Aug 2022	Author responded	Author comments - Yao-kai Chen
Resubmission - Version 4
8 Aug 2022	Submitted	Manuscript version 4
9 Aug 2022	Author responded	Author comments - Yao-kai Chen
Resubmission - Version 5
9 Aug 2022	Submitted	Manuscript version 5
Publishing
18 Aug 2022	Editorially accepted
25 Aug 2022	Article published	10.1186/s12890-022-02118-4

Back to article page